glp-1 agonist fda approval Would love to know what you think about this and where you agree and where you disagree? These are next-generation incretin therapies that are in late-stage clinical development and have the potential FDA Approves First Oral GLP-1

Neuroprotective Effects of Tirzepatide on PD PD is a prevalent neurodegenerative disorder characterized by motor symptoms such as tremors, stiffness, slowness of movement, and balance problems [80]

One recent paper found nearly 39,000 cardiovascular events were avoided when patients had access to obesity treatment, along with improvements in chronic kidney and liver diseases

Monitoring caloric intake to ensure adequate nutrition for milk production

If you have cardiovascular disease, diabetes, sleep apnea, or other eligible diagnosis, ask whether GLP-1 might be appropriate for that indication

Supporting your gut is often the only time people think about immunity during weight loss, but it should be a priority

Thus, there is great interest in optimizing or generating alternative treatments for the many LN patients that fail to respond fully to current therapies